Table 2.

Clinical parameters

	Progression to fibrosis (FP)	Stable disease (SD)
	n = 16	n = 20
Females	6 (38%)	11 (55%)
Age (at diagnosis, mean)	62 years	56 years
Total follow-up	75.5 years	154 years
Range	1.0–12.5 years	4.0–14.0 years
Mean follow-up	5 years	7.3 years
Hemoglobin (g/dL, median)	11.7	14.8
Leukocytes (× 106 × L−1)	16.5	9.2
Thrombocytes (× 109 × L−1)	776	912
Spleen size (mean)	13.4 cm	14.3